SEC Form 4 · accession 0001127602-16-044842
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George A Scangos
Officer — Chief Executive Officer · Director
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2016 | S | 487 | $261.37 | D | 60,921 | D | |
| Common Stock | holding | — | — | — | 5,378 | I | by Trust | |
| Common Stock | holding | — | — | — | 5,378 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.